Edition:
India

Dawnrays Pharmaceutical (Holdings) Ltd (2348.HK)

2348.HK on Hong Kong Stock

4.33HKD
23 Feb 2018
Change (% chg)

HK$-0.03 (-0.69%)
Prev Close
HK$4.36
Open
HK$4.33
Day's High
HK$4.37
Day's Low
HK$4.23
Volume
101,000
Avg. Vol
372,883
52-wk High
HK$5.50
52-wk Low
HK$3.93

Chart for

About

Dawnrays Pharmaceutical (Holdings) Limited is an investment holding company principally engaged in the development, manufacture and sale of non-patented pharmaceutical medicines. The products include intermediate pharmaceutical, bulk medicines and finished drugs. The Company operates its business through two segments. The... (more)

Overall

Beta: 0.57
Market Cap(Mil.): HK$3,569.36
Shares Outstanding(Mil.): 793.19
Dividend: 0.03
Yield (%): 2.89

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.91 10.66
ROE: -- 16.41 14.30

BRIEF-Dawnrays Pharmaceutical (Holdings) Says Li Tung Ming Resigns As Executive Director​

* LI TUNG MING RESIGNED EXECUTIVE DIRECTOR​ Source text for Eikon: Further company coverage:

23 Feb 2018

BRIEF-Dawnrays Pharmaceutical ‍Appoints Chen Shaojun As Executive Director​

* ‍CHEN SHAOJUN, CEO OF CO, HAS BEEN APPOINTED AS AN EXECUTIVE DIRECTOR​

05 Jan 2018

BRIEF-Dawnrays Pharmaceutical (Holdings) Suzhou Dawnrays To Receive RMB351.2 Mln

* UNIT ENTERED RELOCATION COMPENSATION AGREEMENT WITH CHENGNAN STREET OFFICE​

21 Dec 2017

Earnings vs. Estimates